Skip to main content
Log in

QOL data deserve better reporting, standardised use

  • Non-clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Contopoulos-Ioannidis DG, Karvouni A, Kouri I, Ioannidis JPA.Reporting and interpretation of SF-36 outcomes in randomised trials: systematic review. BMJ 338: 152-155, No. 7687, 17 Jan 2009

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

QOL data deserve better reporting, standardised use. Pharmacoecon. Outcomes News 571, 2 (2009). https://doi.org/10.2165/00151234-200905710-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905710-00003

Keywords

Navigation